Chromosome 5p Region SNPs Are Associated with Risk of NSCLC among Women.
In a population-based case-control study, we explored the associations between 42 polymorphisms in seven genes in this region and non-small cell lung cancer (NSCLC) risk among Caucasian (364 cases; 380 controls) and African American (95 cases; 103 controls) women. Two TERT region SNPs, rs2075786 and rs2853677, conferred an increased risk of developing NSCLC, especially among African American women, and TERT-rs2735940 was associated with a decreased risk of lung cancer among African Americans. Five of the 20 GHR polymorphisms and SEPP1-rs6413428 were associated with a marginally increased risk of NSCLC among Caucasians. Random forest analysis reinforced the importance of GHR among Caucasians and identified AMACR, TERT, and GHR among African Americans, which were also significant using gene-based risk scores. Smoking-SNP interactions were explored, and haplotypes in TERT and GHR associated with NSCLC risk were identified. The roles of TERT, GHR, AMACR and SEPP1 genes in lung carcinogenesis warrant further exploration.
Van Dyke
Alison L
AL
Cancer Biology Program, School of Medicine, Wayne State University, 4100 John R, Detroit, MI 48201, USA.
Cote
Michele L
ML
Wenzlaff
Angela S
AS
Abrams
Judith
J
Land
Susan
S
Iyer
Priyanka
P
Schwartz
Ann G
AG
Jpn J Clin Oncol. 2008 Apr;38(4):308-16
18299312
Prostate. 2007 Oct 1;67(14):1507-13
17683075
Prostate. 2007 Oct 1;67(14):1487-97
17680641
Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(6):1829-40
19505916
Mol Psychiatry. 2005 Apr;10(4):407-14
15381926
Lung Cancer. 2007 Apr;56(1):17-23
17175058
Biochem Biophys Res Commun. 1989 Jul 31;162(2):575-82
2527031
Lung Cancer. 2001 Nov;34(2):219-26
11679180
Lung Cancer. 2009 Jul;65(1):34-40
19058871
Appl Immunohistochem Mol Morphol. 2005 Sep;13(3):252-5
16082251
J Med Genet. 2008 Oct;45(10):654-6
18835860
J Korean Med Sci. 2007 Sep;22 Suppl:S47-51
17923754
Eur J Surg Oncol. 2003 Sep;29(7):594-9
12943625
Health Psychol. 1999 Jan;18(1):7-13
9925040
Cancer Res. 2008 Dec 15;68(24):10171-7
19074884
Stat Med. 1996 Feb 28;15(4):361-87
8668867
Cancer Epidemiol Biomarkers Prev. 2008 May;17(5):1144-54
18483336
Genet Epidemiol. 2006 Sep;30(6):485-94
16755519
Bioessays. 2006 Feb;28(2):109-12
16435298
Pharmacogenetics. 1995 Jun;5(3):151-8
7550366
Lung Cancer. 2003 Aug;41(2):163-9
12871779
Environ Res. 1994 Apr;65(1):1-11
8162876
CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96
18287387
Cancer Epidemiol Biomarkers Prev. 2002 Nov;11(11):1285-91
12433704
J Clin Invest. 2008 Feb;118(2):640-50
18172554
Genome Res. 2001 May;11(5):863-74
11337480
Prostate. 2008 Sep 15;68(13):1373-9
18537123
Oncogene. 1998 Mar 5;16(9):1217-22
9528864
Am J Surg Pathol. 2002 Jul;26(7):926-31
12131161
Am J Hum Genet. 2007 Sep;81(3):559-75
17701901
Carcinogenesis. 2007 Aug;28(8):1718-25
17468511
Int J Cancer. 2006 Jun 1;118(11):2903-6
16381017
Br J Cancer. 2007 Sep 17;97(6):832-6
17848914
Pharmacogenet Genomics. 2005 Aug;15(8):547-55
16006998
Pharmacogenetics. 2003 Jun;13(6):339-47
12777964
MedGenMed. 2004 Jul 26;6(3):19
15520642
Nat Genet. 2009 Feb;41(2):221-7
19151717
Nat Genet. 2008 Dec;40(12):1407-9
18978787
Arch Pathol Lab Med. 2007 Oct;131(10):1555-60
17922592
Genome Res. 2006 Jun;16(6):693-701
16741161